Jaguar Health, Inc.
General ticker "JAGX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.5M (TTM average)
Jaguar Health, Inc. does not follow the US Stock Market performance with the rate: -8.7%.
Estimated limits based on current volatility of 6.1%: low 1.04$, high 1.17$
Factors to consider:
- Total employees count: 24 as of 2015
Short-term JAGX quotes
Long-term JAGX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $11.96MM | $9.76MM | $11.69MM |
| Operating Expenses | $46.37MM | $44.05MM | $42.52MM |
| Operating Income | $-34.41MM | $-34.29MM | $-30.83MM |
| Non-Operating Income | $-13.98MM | $-7.61MM | $-8.42MM |
| Interest Expense | $12.72MM | $6.38MM | $0.23MM |
| R&D Expense | $17.65MM | $18.60MM | $16.54MM |
| Income(Loss) | $-48.40MM | $-41.90MM | $-39.25MM |
| Profit(Loss)* | $-47.45MM | $-41.30MM | $-38.49MM |
| Stockholders Equity | $-1.36MM | $4.90MM | $7.29MM |
| Inventory | $7.02MM | $9.19MM | $10.35MM |
| Assets | $47.45MM | $50.76MM | $53.42MM |
| Operating Cash Flow | $-33.10MM | $-33.24MM | $-29.38MM |
| Capital expenditure | $1.68MM | $0.00MM | $0.23MM |
| Investing Cash Flow | $-1.68MM | $0.01MM | $-0.23MM |
| Financing Cash Flow | $23.18MM | $34.23MM | $31.20MM |
| Earnings Per Share** | $-4,058,209.46 | $-2,678.17 | $-130.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.